School of Medicine
  • Print
   
   

Spin-out companies

A number of spin-out companies have been formed by research scientists from the School of Medicine. Click on the logos below to find out more about each of them. 

logo-exonate
Exonate is a biopharmaceutical company focussed on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. 
FaHRAS logo

FaHRAS combines expert advice from leading clinicians with cutting-edge technology.

Gamma Technologies logo

Gamma Technologies focuses on the development of high resolution imaging systems for use in nuclear medicine.

NGD Ltd logo

NGD (Nottingham Gynaecological Devices) Limited is a University of Nottingham spin out company incorporated in July 2006.

NuVision-logo-210x49
NuVision was incorporated on 10 July 2014. The company aims to develop, validate and commercialise innovative and cost effective ophthalmic regenerative therapies to save sight.

Oncimmune

Oncimmune was set up in 2003 to commercialise a test to detect cancer.

new-platelet-solutions

Platelet Solutions was formed in 2011 focussing on platelet function testing in any healthcare setting.

PRECOS logo

PRECOS Limited (Pre-Clinical Oncology Services) develops pre-clinical cancer models relevant to each aspect of cancer progression including pre-malignant lesions, primary tumours and metastasis of a wide range of cancer types.

Scancell

Scancell’s mission is to overcome this breach in our defences by developing products that stimulate the immune system to treat or prevent cancer.

 

 

 

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Please see our 'contact us' page for further details